The tariff classification and country of origin of Naloxone Hydrochloride Injection USP 2 mg/2 mL (1 mg/mL), in dosage form
Reasoning
The tariff classification and country of origin of Naloxone Hydrochloride Injection USP 2 mg/2 mL (1 mg/mL), in dosage form
Cite this ruling
CBP Ruling N312230 (3004490040): The tariff classification and country of origin of Naloxone Hydrochloride Injection USP 2 mg/2 mL (1 mg/mL), in dosage form
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300449
The tariff classification of Metaraminol Bitartrate Injection USP in dosage form, from India
The tariff classification of Theophylline Extended-Release Tablets from Germany and Mirabegron Extended-Release Tablets from India
The tariff classification of Scopolamine Transdermal System from Australia and Pitavastatin Tablets from India
The tariff classification of Paroxetine Hydrochloride Tablets in dosage form, from India
The tariff classification of Colchicine Tablets in dosage form, from Italy